M13 Phage Engineered to Capture SARS-CoV-2 Virus
Summary
M13 Phage Engineered to Capture SARS-CoV-2 Virus
Archived snapshot
Apr 10, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ENGINEERED PHAGE AND KIT FOR CAPTURING SARS-COV-2 AND METHOD FOR DETECTING SARS-COV-2 VIRUS BY MEANS OF SAID PHAGE OR KIT
Application US20260098861A1 Kind: A1 Apr 09, 2026
Inventors
Salvatore GUGLIELMINO, Maria Giovanna RIZZO, Nicoletta PALERMO, Marco Sebastiano NICOLO', Emanuele Luigi SCIUTO, Matteo CALVARESI, Alberto DANIELLI, Luca PRODI, Sabrina CONOCI
Abstract
A phage for the specific capture of the SARS-CoV-2 virus, said phage being an M13 phage engineered to display on the P8 protein of its coat either FHKGGYEKTWKLGD sequence peptides or EFTSKAR sequence peptides, said peptides having specific affinity for the Spike S1 protein of the SARS-CoV-2 virus.
CPC Classifications
G01N 33/56983 C12N 7/00 G01N 33/54326 C12N 2795/14121 G01N 2333/165
Filing Date
2023-09-28
Application No.
19116251
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.